Submit Deal

GALAPAGOS (JYSELECA BUSINESS)

Summary

Jyseleca is a medicine for treating adults with: moderate to severe rheumatoid arthritis and moderately to severely active ulcerative colitis.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 148 M

Avg. Deal Size£ 148 M

Market Context

Sort

Target: GALAPAGOS (JYSELECA BUSINESS)

Bidder: ALFASIGMA SPA

14 Service Providers

23 Dealmakers

£ 148 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy